The movement to personalize treatment for breast cancer proceeds apace, as evidenced by two corresponding studies published May 2 in Nature and Nature Communications.
In one study, researchers found five new genes that seem to play a role in turning breast-tissue cells into cancer cells.
In the other, investigators got “the first large-scale view of the [entire] genome, uncovering some new reasons why breast cancer arises,” says co-author Ewan Birney, PhD, of the European Bioinformatics Institute in prepared remarks published in Time.
This, he adds, gave them “an unexpected way to characterize the types of mutations that happen in certain breast cancers.”
Study author Serena Nik-Zainal, PhD, of the Wellcome Trust Sanger Institute in England tells Time: “As we gather more and more data, we will learn more about each cancer and improve on our methods to treat everyone more efficiently and more effectively.”
Click below for the Time article:
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.